Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Humans | 30 | 2023 | 2493 | 0.950 |
Why?
|
| African Americans | 8 | 2016 | 272 | 0.930 |
Why?
|
| Neoplasms | 5 | 2015 | 54 | 0.900 |
Why?
|
| Community-Based Participatory Research | 5 | 2015 | 25 | 0.870 |
Why?
|
| Community Health Services | 4 | 2017 | 22 | 0.810 |
Why?
|
| Poverty | 3 | 2016 | 39 | 0.770 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2019 | 9 | 0.710 |
Why?
|
| Community-Institutional Relations | 3 | 2017 | 14 | 0.660 |
Why?
|
| Middle Aged | 17 | 2023 | 799 | 0.620 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2015 | 64 | 0.610 |
Why?
|
| Female | 18 | 2019 | 1733 | 0.600 |
Why?
|
| Medically Uninsured | 2 | 2016 | 6 | 0.590 |
Why?
|
| Male | 19 | 2019 | 1649 | 0.570 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2016 | 2 | 0.570 |
Why?
|
| Patient Navigation | 1 | 2016 | 3 | 0.570 |
Why?
|
| Health Status Disparities | 4 | 2015 | 41 | 0.540 |
Why?
|
| Albuminuria | 2 | 2012 | 20 | 0.520 |
Why?
|
| Cooperative Behavior | 3 | 2014 | 15 | 0.510 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2014 | 1 | 0.500 |
Why?
|
| Lymph Nodes | 1 | 2014 | 4 | 0.500 |
Why?
|
| Myometrium | 1 | 2014 | 7 | 0.490 |
Why?
|
| Aged | 13 | 2023 | 607 | 0.490 |
Why?
|
| Urban Health Services | 1 | 2014 | 18 | 0.490 |
Why?
|
| Adult | 14 | 2019 | 807 | 0.490 |
Why?
|
| Endometrial Neoplasms | 1 | 2014 | 17 | 0.490 |
Why?
|
| Kidney Failure, Chronic | 1 | 2012 | 29 | 0.450 |
Why?
|
| Los Angeles | 9 | 2023 | 210 | 0.430 |
Why?
|
| Mass Screening | 1 | 2012 | 66 | 0.430 |
Why?
|
| Breast Neoplasms | 3 | 2015 | 167 | 0.390 |
Why?
|
| Quality of Health Care | 1 | 2008 | 10 | 0.340 |
Why?
|
| Organizational Case Studies | 1 | 2008 | 1 | 0.330 |
Why?
|
| Health Education | 1 | 2008 | 18 | 0.330 |
Why?
|
| Cardiovascular Diseases | 2 | 2007 | 36 | 0.310 |
Why?
|
| Models, Cardiovascular | 1 | 2007 | 1 | 0.310 |
Why?
|
| Social Welfare | 1 | 2006 | 1 | 0.300 |
Why?
|
| Interdisciplinary Communication | 1 | 2006 | 3 | 0.300 |
Why?
|
| Patient Care Management | 1 | 2006 | 2 | 0.300 |
Why?
|
| Medicaid | 2 | 2007 | 7 | 0.280 |
Why?
|
| HIV Infections | 1 | 2006 | 91 | 0.280 |
Why?
|
| Diabetes Mellitus | 2 | 2019 | 114 | 0.280 |
Why?
|
| Health Services | 1 | 2004 | 9 | 0.260 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2007 | 148 | 0.260 |
Why?
|
| Clinical Medicine | 1 | 2004 | 1 | 0.250 |
Why?
|
| Health Services Research | 1 | 2004 | 21 | 0.250 |
Why?
|
| Risk Assessment | 4 | 2019 | 55 | 0.230 |
Why?
|
| Residence Characteristics | 2 | 2016 | 19 | 0.220 |
Why?
|
| Telemedicine | 1 | 2023 | 31 | 0.220 |
Why?
|
| Adolescent | 6 | 2017 | 305 | 0.220 |
Why?
|
| Insurance Coverage | 2 | 2016 | 9 | 0.220 |
Why?
|
| Prognosis | 3 | 2019 | 47 | 0.190 |
Why?
|
| Comprehensive Health Care | 1 | 2019 | 1 | 0.190 |
Why?
|
| Medical Record Linkage | 1 | 2019 | 6 | 0.190 |
Why?
|
| Electronic Health Records | 1 | 2019 | 17 | 0.180 |
Why?
|
| Qualitative Research | 2 | 2017 | 21 | 0.180 |
Why?
|
| Healthcare Disparities | 3 | 2015 | 27 | 0.180 |
Why?
|
| Developing Countries | 2 | 2009 | 15 | 0.170 |
Why?
|
| Health Behavior | 3 | 2015 | 37 | 0.170 |
Why?
|
| Early Detection of Cancer | 2 | 2015 | 32 | 0.160 |
Why?
|
| Community Health Workers | 2 | 2008 | 10 | 0.160 |
Why?
|
| Perception | 2 | 2015 | 13 | 0.160 |
Why?
|
| Religion | 1 | 2017 | 1 | 0.160 |
Why?
|
| Allostasis | 1 | 2017 | 1 | 0.160 |
Why?
|
| Hypertension | 3 | 2019 | 56 | 0.150 |
Why?
|
| Mortality | 1 | 2017 | 11 | 0.150 |
Why?
|
| United States | 4 | 2019 | 324 | 0.150 |
Why?
|
| Safety-net Providers | 1 | 2017 | 17 | 0.150 |
Why?
|
| Health Promotion | 1 | 2017 | 31 | 0.150 |
Why?
|
| Risk Factors | 4 | 2019 | 240 | 0.150 |
Why?
|
| Vulnerable Populations | 1 | 2017 | 31 | 0.150 |
Why?
|
| Young Adult | 5 | 2017 | 175 | 0.150 |
Why?
|
| Chicago | 1 | 2016 | 1 | 0.140 |
Why?
|
| Health Status | 1 | 2016 | 39 | 0.140 |
Why?
|
| Research Subjects | 1 | 2015 | 4 | 0.140 |
Why?
|
| Patient Selection | 1 | 2015 | 13 | 0.140 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 19 | 0.140 |
Why?
|
| Trust | 1 | 2015 | 9 | 0.140 |
Why?
|
| Chronic Disease | 3 | 2016 | 70 | 0.130 |
Why?
|
| Feeding Behavior | 2 | 2012 | 26 | 0.130 |
Why?
|
| SEER Program | 1 | 2014 | 3 | 0.120 |
Why?
|
| Neoplasm Grading | 1 | 2014 | 5 | 0.120 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 4 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 14 | 0.120 |
Why?
|
| Risk | 1 | 2014 | 19 | 0.120 |
Why?
|
| Delphi Technique | 1 | 2014 | 2 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2014 | 7 | 0.120 |
Why?
|
| Tumor Burden | 1 | 2014 | 15 | 0.120 |
Why?
|
| Aged, 80 and over | 5 | 2015 | 246 | 0.120 |
Why?
|
| Program Development | 1 | 2014 | 15 | 0.120 |
Why?
|
| Universities | 1 | 2014 | 7 | 0.120 |
Why?
|
| Stress, Psychological | 1 | 2014 | 20 | 0.120 |
Why?
|
| Retrospective Studies | 1 | 2014 | 210 | 0.120 |
Why?
|
| Internet | 1 | 2012 | 12 | 0.110 |
Why?
|
| Nutrition Assessment | 1 | 2012 | 6 | 0.110 |
Why?
|
| Acute Kidney Injury | 2 | 2009 | 2 | 0.110 |
Why?
|
| Cross-Sectional Studies | 4 | 2023 | 267 | 0.110 |
Why?
|
| Mortality, Premature | 1 | 2011 | 1 | 0.110 |
Why?
|
| Socioeconomic Factors | 4 | 2015 | 116 | 0.110 |
Why?
|
| Fatigue | 1 | 2011 | 1 | 0.100 |
Why?
|
| Acupuncture Therapy | 1 | 2011 | 2 | 0.100 |
Why?
|
| Self Care | 1 | 2011 | 16 | 0.100 |
Why?
|
| Violence | 1 | 2011 | 37 | 0.100 |
Why?
|
| Patient Education as Topic | 1 | 2011 | 31 | 0.100 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2010 | 2 | 0.100 |
Why?
|
| Health Surveys | 2 | 2008 | 39 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2010 | 37 | 0.090 |
Why?
|
| Leptospirosis | 1 | 2009 | 1 | 0.090 |
Why?
|
| Snake Bites | 1 | 2009 | 1 | 0.090 |
Why?
|
| Zoonoses | 1 | 2009 | 2 | 0.090 |
Why?
|
| Age Factors | 3 | 2017 | 90 | 0.090 |
Why?
|
| Creatinine | 1 | 2008 | 10 | 0.090 |
Why?
|
| Case Management | 1 | 2008 | 4 | 0.080 |
Why?
|
| Body Mass Index | 3 | 2015 | 46 | 0.080 |
Why?
|
| Food Supply | 1 | 2008 | 4 | 0.080 |
Why?
|
| Prevalence | 3 | 2019 | 114 | 0.080 |
Why?
|
| Consensus | 1 | 2008 | 4 | 0.080 |
Why?
|
| Education | 1 | 2008 | 7 | 0.080 |
Why?
|
| Public Health | 1 | 2008 | 15 | 0.080 |
Why?
|
| Registries | 2 | 2019 | 18 | 0.080 |
Why?
|
| Insurance, Health | 1 | 2007 | 10 | 0.080 |
Why?
|
| Long-Term Care | 1 | 2007 | 3 | 0.080 |
Why?
|
| Antihypertensive Agents | 1 | 2007 | 28 | 0.080 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2006 | 14 | 0.070 |
Why?
|
| Surveys and Questionnaires | 2 | 2017 | 97 | 0.060 |
Why?
|
| Risk-Taking | 2 | 2015 | 35 | 0.060 |
Why?
|
| Capital Financing | 1 | 2004 | 1 | 0.060 |
Why?
|
| Fellowships and Scholarships | 1 | 2004 | 1 | 0.060 |
Why?
|
| Internal Medicine | 1 | 2004 | 1 | 0.060 |
Why?
|
| Education, Medical, Continuing | 1 | 2004 | 5 | 0.060 |
Why?
|
| Teaching | 1 | 2004 | 3 | 0.060 |
Why?
|
| Forecasting | 1 | 2004 | 10 | 0.060 |
Why?
|
| Pandemics | 1 | 2023 | 22 | 0.060 |
Why?
|
| Diet | 2 | 2012 | 40 | 0.050 |
Why?
|
| Quality Improvement | 1 | 2019 | 10 | 0.050 |
Why?
|
| Disease Progression | 1 | 2019 | 50 | 0.050 |
Why?
|
| Causality | 2 | 2009 | 4 | 0.040 |
Why?
|
| Brazil | 2 | 2009 | 7 | 0.040 |
Why?
|
| Comorbidity | 2 | 2009 | 54 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2009 | 119 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 10 | 0.040 |
Why?
|
| Healthy Lifestyle | 1 | 2017 | 1 | 0.040 |
Why?
|
| Cause of Death | 1 | 2017 | 14 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 10 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 26 | 0.040 |
Why?
|
| Algorithms | 1 | 2017 | 33 | 0.040 |
Why?
|
| Environment Design | 1 | 2016 | 2 | 0.040 |
Why?
|
| Community Health Centers | 1 | 2016 | 7 | 0.040 |
Why?
|
| Marketing of Health Services | 1 | 2015 | 3 | 0.030 |
Why?
|
| Survival Rate | 1 | 2015 | 23 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2015 | 8 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2015 | 29 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2015 | 56 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2015 | 21 | 0.030 |
Why?
|
| Animals | 2 | 2009 | 1238 | 0.030 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2015 | 77 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2012 | 6 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2012 | 21 | 0.030 |
Why?
|
| Focus Groups | 1 | 2012 | 23 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2012 | 28 | 0.030 |
Why?
|
| Physicians | 1 | 2012 | 16 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2011 | 1 | 0.030 |
Why?
|
| Social Support | 1 | 2011 | 26 | 0.030 |
Why?
|
| Relaxation Therapy | 1 | 2011 | 1 | 0.030 |
Why?
|
| Integrative Medicine | 1 | 2011 | 1 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 2011 | 3 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2011 | 7 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2011 | 10 | 0.030 |
Why?
|
| Exercise | 1 | 2011 | 24 | 0.030 |
Why?
|
| Castration | 1 | 2010 | 14 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 19 | 0.020 |
Why?
|
| Austria | 1 | 2010 | 2 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 95 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2010 | 33 | 0.020 |
Why?
|
| Sex Factors | 1 | 2010 | 75 | 0.020 |
Why?
|
| Antivenins | 1 | 2009 | 1 | 0.020 |
Why?
|
| Rodentia | 1 | 2009 | 1 | 0.020 |
Why?
|
| Bothrops | 1 | 2009 | 1 | 0.020 |
Why?
|
| Crotalus | 1 | 2009 | 1 | 0.020 |
Why?
|
| Penicillins | 1 | 2009 | 3 | 0.020 |
Why?
|
| Doxycycline | 1 | 2009 | 4 | 0.020 |
Why?
|
| Urban Health | 1 | 2009 | 11 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2009 | 5 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 24 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2009 | 18 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2009 | 35 | 0.020 |
Why?
|
| Biomarkers | 1 | 2008 | 58 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2008 | 7 | 0.020 |
Why?
|
| Poverty Areas | 1 | 2008 | 10 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2008 | 42 | 0.020 |
Why?
|
| Drug Costs | 1 | 2007 | 4 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2007 | 35 | 0.020 |
Why?
|
| Medicare | 1 | 2007 | 19 | 0.020 |
Why?
|
| Social Class | 1 | 2007 | 25 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2007 | 40 | 0.020 |
Why?
|
| Reference Values | 1 | 2006 | 42 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 49 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2006 | 18 | 0.020 |
Why?
|